Predictors of long-term drug survival for infliximab in psoriasis

被引：0

作者：

Magis, Q. ^{[1
]}

Jullien, D. ^{[2
]}

Gaudy, C. ^{[1
]}

Baumstark, K. ^{[3
]}

Viguier, M. ^{[4
]}

Bachelez, H. ^{[5
]}

Guibal, F. ^{[6
]}

Delaporte, E. ^{[7
]}

Karimova, E. ^{[7
]}

Montaudie, H. ^{[8
]}

Boye, T. ^{[9
]}

Aubin, F. ^{[10
]}

Beylot-Barry, M. ^{[11
]}

Richard, M. -A. ^{[1
]}

机构：

[1] Hop La Timone, Dermatol, Marseille, France

[2] Hop Edouard Herriot, Lyon, France

[3] Aix Marseille Univ, Clin Res, Marseille, France

[4] Hop La Sorbonne, Dermatol, Paris, France

[5] Hop St Louis, Paris, France

[6] Hop St Louis, Dermatol, Paris, France

[7] Reg Univ Hosp, Lille, France

[8] Hop LArchet, Nice, France

[9] Hop Instruct Armees St Anne, Dermatol, Toulon, France

[10] Hop Jean Minjoz, Dermatoloie, Besancon, France

[11] Hop St Andre, Dermatol, Bordeaux, France

来源：

关键词：

infliximab; long-term drug survival; predictors of long term survival;

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P192

引用

页码：96 / 97

页数：2